interstitial cystitis
Conditions
Interventions
group A:oral sildenafil
group B:oral placebo
Sponsors
The First Af?liated Hospital of Wenzhou Medical College
Eligibility
Sex/Gender
All
Age
35 Years to 55 Years
Inclusion criteria
Inclusion criteria: All patients underwent the following diagnostic tests: positive modified potassium sensitivity test [17], cystoscopic findings of over 10 glomerulations and non-ulcer lesion in every visual field after hydrodistention (pressure: 80-100 cmH2O, duration: 2 min) under sedation or spinal anesthesia at the discretion of the clinician.
Exclusion criteria
Exclusion criteria: Patients with diabetes mellitus, mental disorder, hypertension, hypohepatia, renal insufficiency or received any treatment for IC/PBS with 3 months were excluded. Patients observed for 1 month to eliminate interference of hydrodistention. Those still having therapeutic response to hydrodistention after 1 month were also excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| urodynamic indices;interstitial cystitis symptom indices(ICSI);interstitial cystitis problem indices (ICPI);micturition diar; | — |
Countries
China
Contacts
Public ContactHongde Chen
The First Affiliated Hospital of Wenzhou Medical College
Outcome results
None listed